JAMA Oncology Author Interviews

Interview with Katrina A. B. Goddard, PhD, author of Estimation of Cancer Deaths Averted From Prevention, Screening, and Treatment Efforts, 1975-2020. Hosted by Vivek Subbiah, MD. Related Content: * Estimation of Cancer Deaths Averted From Prevention, Screening, and Treatment Efforts, 1975-2020 [https://jamanetwork.com/journals/jamaoncology/fullarticle/10.1001/jamaoncol.2024.5381?utm_source=podcast_platforms&utm_medium=referral&utm_campaign=related_article_links]

Interview with Hagop Kantarjian, MD, author of Olverembatinib After Failure of Tyrosine Kinase Inhibitors, Including Ponatinib or Asciminib: A Phase 1b Randomized Clinical Trial. Hosted by Vivek Subbiah, MD. Related Content: * Olverembatinib After Failure of Tyrosine Kinase Inhibitors, Including Ponatinib or Asciminib [https://jamanetwork.com/journals/jamaoncology/fullarticle/10.1001/jamaoncol.2024.5157?utm_source=podcast_platforms&utm_medium=referral&utm_campaign=related_article_links]

Interview with Maria E. Cabanillas, MD, author of Anti–Programmed Death Ligand 1 Plus Targeted Therapy in Anaplastic Thyroid Carcinoma: A Nonrandomized Clinical Trial. Hosted by Vivek Subbiah, MD. Related Content: * Anti–Programmed Death Ligand 1 Plus Targeted Therapy in Anaplastic Thyroid Carcinoma [https://jamanetwork.com/journals/jamaoncology/fullarticle/10.1001/jamaoncol.2024.4729?utm_source=podcast_platforms&utm_medium=referral&utm_campaign=related_article_links]

Interview with Eileen M. O’Reilly, MD, author of Lynch Syndrome and Somatic Mismatch Repair Variants in Pancreas Cancer. Hosted by Vivek Subbiah, MD. Related Content: * Lynch Syndrome and Somatic Mismatch Repair Variants in Pancreas Cancer [https://jamanetwork.com/journals/jamaoncology/fullarticle/10.1001/jamaoncol.2024.3651?utm_source=podcast_platforms&utm_medium=referral&utm_campaign=related_article_links]

Interview with Michelle Rengarajan, MD, PhD, author of Identification of Immune Checkpoint Inhibitor–Induced Diabetes. Hosted by Vivek Subbiah, MD. Related Content: * Identification of Immune Checkpoint Inhibitor–Induced Diabetes [https://jamanetwork.com/journals/jamaoncology/fullarticle/10.1001/jamaoncol.2024.3104?utm_source=podcast_platforms&utm_medium=referral&utm_campaign=related_article_links]